Dendritic Cell Cancer Vaccine for High-grade Glioma

NCT01213407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Trivax, Temozolomide, Surgery, Radiotherapy
DRUG: Temozolomide, Surgery, Radiotherapy

Sponsor

Activartis Biotech